Work productivity in rhinitis using cell phones: The MASK pilot study

被引：77

作者：

Bousquet, J. ^{[1
,2
,3
]}

Bewick, M. ^{[4
]}

Arnavielhe, S. ^{[5
]}

Mathieu-Dupas, E. ^{[5
]}

Murray, R. ^{[6
]}

Bedbrook, A. ^{[1
]}

Caimmi, D. P. ^{[7
,8
]}

Vandenplas, O. ^{[9
]}

Hellings, P. W. ^{[10
]}

Bachert, C. ^{[11
]}

Anto, J. M. ^{[12
,13
]}

Bergmann, K. C. ^{[14
]}

Bindslev-Jensen, C. ^{[15
,16
]}

Bosnic-Anticevich, S. ^{[17
,18
]}

Bouchard, J. ^{[19
,20
]}

Canonica, G. W. ^{[21
]}

Chavannes, N. H. ^{[22
]}

Cruz, A. A. ^{[23
,24
]}

Dahl, R. ^{[23
,24
]}

Demoly, P. ^{[8
]}

De Vries, G. ^{[25
]}

Devillier, P. ^{[26
]}

Fink-Wagner, A. ^{[27
]}

Fokkens, W. J. ^{[28
]}

Fonseca, J. ^{[29
,30
]}

Guldemond, N. A. ^{[31
]}

Haahtela, T. ^{[32
]}

Hellqvist-Dahl, B. ^{[33
]}

Just, J. ^{[34
,35
]}

Keil, T. ^{[36
,37
]}

Klimek, L. ^{[38
]}

Kowalski, M. L. ^{[39
,40
]}

Kuna, P. ^{[41
]}

Kvedariene, V. ^{[42
]}

Laune, D. ^{[5
]}

Larenas-Linnemann, D. ^{[43
]}

Mullol, J. ^{[44
]}

Pereira, A. M. ^{[45
,46
,47
]}

Carreiro-Martins, P. ^{[48
,49
]}

En, E. Mel ^{[50
]}

Morais-Almeida, M. ^{[51
]}

Nogueira-Silva, L. ^{[52
,53
]}

O'Hehir, R. E. ^{[54
,55
,56
]}

Papadopoulos, N. G. ^{[57
,58
]}

Passalacqua, G. ^{[59
]}

Portejoie, F. ^{[1
]}

Price, D. ^{[60
,61
,62
]}

Ryan, D. ^{[63
]}

Samolinski, B. ^{[64
]}

Sheikh, A. ^{[65
]}

机构：

[1] MACVIA France, MAlad Chron Vleillissement Actif France European, Montpellier, France

[2] INSERM U1168, VIMA Ageing & Chron Dis Epidemiol & Publ Hlth App, Villejuif, France

[3] Univ Versailles St Quentin En Yvelines, UMR S 1168, Montigny Le Bretonneux, France

[4] iQ4U Consultants Ltd, London, England

[5] Kyomed, Montpellier, France

[6] MedScript Ltd, Dundalk, Louth, Ireland

[7] UPMC Paris 06, Sorbonne Univ, UMR S 1136, IPLESP,Equipe EPAR, Paris, France

[8] Montpellier Univ Hosp, Dept Resp Dis, Montpellier, France

[9] Catholic Univ Louvain, Ctr Hosp Univ UCL Namur, Dept Chest Med, Yvoir, Belgium

[10] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Clin Immunol, Leuven, Belgium

[11] Ghent Univ Hosp, ENT Dept, Upper Airways Res Lab, Ghent, Belgium

[12] IMIM Hosp Mar Res Inst, CIBERESP, Ctr Res Environm Epidemiol CREAL, ISGLoBAL, Barcelona, Spain

[13] UPF, Barcelona, Spain

[14] Charite, Dept Dermatol & Allergy, Comprehens Allergy Ctr Charite, Global Allergy & Asthma European Network GA2LEN, Berlin, Germany

[15] Odense Univ Hosp, Dept Dermatol, Odense, Denmark

[16] Odense Univ Hosp, Allergy Ctr, Odense, Denmark

[17] Univ Sydney, Woolcock Inst Med Res, Glebe, NSW, Australia

[18] Sydney Local Hlth Dist, Glebe, NSW, Australia

[19] Lavals Unit, Clin Med, Quebec City, PQ, Canada

[20] Hop La Malbaie, La Malbaie, PQ, Canada

[21] Humanitas Univ, Humanitas Res Hosp, Personalized Med Clin Asthma & Allergy, Milan, Italy

[22] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands

[23] Univ Fed Bahia, ProAR Nucleo Excelencia Asma, Salvador, BA, Brazil

[24] GARD Execut Comm, Salvador, BA, Brazil

[25] Peercode DV, Gerdermalsen, Netherlands

[26] Hop Foch, Pole Malad Resp, Lab Pharmacol Resp UPRES EA220, Suresnes, France

[27] Global Allergy & Asthma Platform GAAPP, Vienna, Austria

[28] Acad Med Ctr, Dept Otorhinolaryngol, Amsterdam, Netherlands

[29] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, Porto, Portugal

[30] CUF Porto Inst & Hosp, Allergy Unit, Porto, Portugal

[31] Erasmus Univ, Inst Hlth Policy & Management iBMG, Rotterdam, Netherlands

[32] Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland

[33] Odense Univ Hosp, Dept Resp Dis, Odense, Denmark

[34] Hop Enfants Armand Trousseau, AP HP, Ctr Asthme & Allergies, Allergol Dept, Paris, France

[35] UPMC Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136,Equipe EPAR, Paris, France

[36] Charite, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany

[37] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany

[38] Ctr Rhinol & Allergol, Wiesbaden, Germany

[39] Med Univ Lodz, Dept Immunol Rheumatol & Allergy, Lodz, Poland

[40] HARC, Lodz, Poland

[41] Med Univ Lodz, Barlicki Univ Hosp, Div Internal Med Asthma & Allergy, Lodz, Poland

[42] Vilnius Univ, Clin Infect Chest Dis Dermatol & Allergol, Vilnius, Lithuania

[43] Hosp Med Sur, Clin Alergia Asma & Pediat, Mexico City, DF, Mexico

[44] Univ Barcelona, IDIBAPS, Hosp Clin, Clin & Expt Resp Immunoallergy,ENT Dept, Barcelona, Spain

[45] CUF Descobertas Hosp, Immunoallergy Dept, Lisbon, Portugal

[46] Univ Porto, Fac Med, Hlth Informat & Decis Sci Dept, Porto, Portugal

[47] CUF Porto Hosp & Inst, Allergy Unit, Porto, Portugal

[48] Nova Med Sch, Resp Res Grp, CEDOC, Campo Martires Patria, Lisbon, Portugal

[49] Ctr Hosp Lisboa Cent, EPE, Serv Imunoalergol, Lisbon, Portugal

[50] Karolinska Inst, Inst Environm Med, Sodersjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden

来源：

ALLERGY | 2017年 / 72卷 / 10期

关键词：

Allergic Rhinitis and its Impact on Asthma; app; rhinitis; work productivity; WPAIA:AS; QUALITY-OF-LIFE; ALLERGIC RHINITIS; RESOURCE UTILIZATION; HEALTH-ORGANIZATION; EUROPEAN COUNTRIES; ECONOMIC BURDEN; IMPACT; DISEASES; ASTHMA; SYMPTOMS;

D O I：

10.1111/all.13177

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI: AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P<0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI: AS (Rho=0.53, P<0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms.

引用

页码：1475 / 1484

页数：10

共 42 条

[1] The work impact of asthma and rhinitis: Findings from a population-based survey
Blanc, PD
Trupin, L
Eisner, M
Earnest, G
Katz, PP
Israel, L
Yelin, EH
[J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (06) : 610 - 618
[2] REGRESSION-ANALYSIS
BLAND, JM
ALTMAN, DG
[J]. LANCET, 1986, 1 (8486) : 908 - 909
[3] Bourret Rodolphe, 2015, World Hosp Health Serv, V51, P36
[4] Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen)
Bousquet, J.
Khaltaev, N.
Cruz, A. A.
Denburg, J.
Fokkens, W. J.
Togias, A.
Zuberbier, T.
Baena-Cagnani, C. E.
Canonica, G. W.
van Weel, C.
Agache, I.
Ait-Khaled, N.
Bachert, C.
Blaiss, M. S.
Bonini, S.
Boulet, L. -P.
Bousquet, P. -J.
Camargos, P.
Carlsen, K. -H.
Chen, Y.
Custovic, A.
Dahl, R.
Demoly, P.
Douagui, H.
Durham, S. R.
van Wijk, R. Gerth
Kalayci, O.
Kaliner, M. A.
Kim, Y. -Y.
Kowalski, M. L.
Kuna, P.
Le, L. T. T.
Lemiere, C.
Li, J.
Lockey, R. F.
Mavale-Manuel, S.
Meltzer, E. O.
Mohammad, Y.
Mullol, J.
Naclerio, R.
Hehir, R. E. O.
Ohta, K.
Ouedraogo, S.
Palkonen, S.
Papadopoulos, N.
Passalacqua, G.
Pawankar, R.
Popov, T. A.
Rabe, K. F.
Rosado-Pinto, J.
[J]. ALLERGY, 2008, 63 : 8 - +
[5] Severity and impairment of allergic rhinitis in patients consulting in primary care
Bousquet, J
Neukirch, F
Bousquet, PJ
Gehano, P
Klossek, JM
Le Gal, M
Allaf, B
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) : 158 - 162
[6] Costs associated with persistent allergic rhinitis are reduced by levocetirizine
Bousquet, J
Demarteau, N
Mullol, J
van den Akker-van Marle, ME
Van Ganse, E
Bachert, C
[J]. ALLERGY, 2005, 60 (06) : 788 - 794
[7] Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study
Bousquet, J.
Caimmi, D. P.
Bedbrook, A.
Bewick, M.
Hellings, P. W.
Devillier, P.
Arnavielhe, S.
Bachert, C.
Bergmann, K. C.
Canonica, G. W.
Chavannes, N. H.
Cruz, A. A.
Dahl, R.
Demoly, P.
De Vries, G.
Mathieu-Dupas, E.
Finkwagner, A.
Fonseca, J.
Guldemond, N.
Haahtela, T.
Hellqvist-Dahl, B.
Just, J.
Keil, T.
Klimek, L.
Kowalski, M. L.
Kuitunen, M.
Kuna, P.
Kvedariene, V.
Laune, D.
Pereira, A. M.
Carreiro-Martins, P.
Melen, E.
Morais-Almeida, M.
Mullol, J.
Muraro, A.
Murray, R.
Nogueira-Silva, L.
Papadopoulos, N. G.
Passalacqua, G.
Portejoie, F.
Price, D.
Ryan, D.
Samolinski, B.
Sheikh, A.
Siroux, V.
Spranger, O.
Bom, A. Todo
Tomazic, P. V.
Valero, A.
Valovirta, E.
[J]. ALLERGY, 2017, 72 (06) : 857 - 865
[8] MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
Bousquet, J.
Schunemann, H. J.
Fonseca, J.
Samolinski, B.
Bachert, C.
Canonica, G. W.
Casale, T.
Cruz, A. A.
Demoly, P.
Hellings, P.
Valiulis, A.
Wickman, M.
Zuberbier, T.
Bosnic-Anticevitch, S.
Bedbrook, A.
Bergmann, K. C.
Caimmi, D.
Dahl, R.
Fokkens, W. J.
Grisle, I.
Lodrup Carlsen, K.
Mullol, J.
Muraro, A.
Palkonen, S.
Papadopoulos, N.
Passalacqua, G.
Ryan, D.
Valovirta, E.
Yorgancioglu, A.
Aberer, W.
Agache, I.
Adachi, M.
Akdis, C. A.
Akdis, M.
Annesi-Maesano, I.
Ansotegui, I. J.
Anto, J. M.
Arnavielhe, S.
Arshad, H.
Baiardini, I.
Baigenzhin, A. K.
Barbara, C.
Bateman, E. D.
Beghe, B.
Bel, E. H.
Ben Kheder, A.
Bennoor, K. S.
Benson, M.
Bewick, M.
Bieber, T.
[J]. ALLERGY, 2015, 70 (11) : 1372 - 1392
[9] The European Innovation Partnership on Active and Healthy Ageing: The European geriatric medicine introduces the EIP on AHA column
Bousquet, J.
Michel, J. -P.
Strandberg, T.
Crooks, G.
Iakovidis, I.
Iglesia, M.
[J]. EUROPEAN GERIATRIC MEDICINE, 2014, 5 (06) : 361 - 362
[10] Integrated care pathways for airway diseases (AIRWAYS-ICPs)
Bousquet, J.
Addis, A.
Adcock, I.
Agache, I.
Agusti, A.
Alonso, A.
Annesi-Maesano, I.
Anto, J. M.
Bachert, C.
Baena-Cagnani, C. E.
Bai, C.
Baigenzhin, A.
Barbara, C.
Barnes, P. J.
Bateman, E. D.
Beck, L.
Bedbrook, A.
Bel, E. H.
Benezet, O.
Bennoor, K. S.
Benson, M.
Bernabeu-Wittel, M.
Bewick, M.
Bindslev-Jensen, C.
Blain, H.
Blasi, F.
Bonini, M.
Bonini, S.
Boulet, L. P.
Bourdin, A.
Bourret, R.
Bousquet, P. J.
Brightling, C. E.
Briggs, A.
Brozek, J.
Buhl, R.
Bush, A.
Caimmi, D.
Calderon, M.
Calverley, P.
Camargos, P. A.
Camuzat, T.
Canonica, G. W.
Carlsen, K. H.
Casale, T. B.
Cazzola, M.
Sarabia, A. M. Cepeda
Cesario, A.
Chen, Y. Z.
Chkhartishvili, E.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (02) : 304 - 323

← 1 2 3 4 5 →